stockrowPrestige Consumer Healthcare Inc.
PBH Healthcare Drug Manufacturers Specialty & Generic
Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.
- Revenue
- +22.7%
- EPS
- −38.4%
- Free cash flow
- −38.2%
- Total debt
- +100.9%
Quarter to September 2026, against a year earlier
Follow PBH
Alert me
Prestige Consumer Healthcare Inc. (PBH) Operating margin
Prestige Consumer Healthcare Inc.'s operating margin over the twelve months to 30 September 2026 was 25.0%, down 3.5 percentage points from fiscal 2026 (28.4%). Over the past ten years it has ranged from −1.99% (fiscal 2023) to 32.3% (fiscal 2016); the current reading is higher than 42% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2026 | 28.4% | (1.18) |
| FY2025 | 29.6% | (0.83) |
| FY2024 | 30.4% | 32.42 |
| FY2023 | −1.99% | (32.35) |
| FY2022 | 30.4% | (1.17) |
| FY2021 | 31.5% | 1.30 |
| FY2020 | 30.2% | 23.31 |
| FY2019 | 6.92% | (13.78) |
| FY2018 | 20.7% | (2.61) |
| FY2017 | 23.3% | (8.98) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 24.0% | 4.23 |
| Jun 2026 | 19.8% | (7.04) |
| Mar 2026 | 26.8% | (2.29) |
| Dec 2025 | 29.1% | 0.04 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| PBH Prestige Consumer Healthcare Inc. | 25.0% |
| XERS Xeris Biopharma Holdings, Inc. compare | 12.7% |
| TRLV Trulieve Cannabis Corp. compare | 0.00% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.00% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.00% |
| BCRX BioCryst Pharmaceuticals, Inc. compare | −30.1% |
| PRGO Perrigo Company plc compare | −39.4% |
| ALVO Alvotech compare | −42.4% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on PBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement